Palogic Value Management’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
VCM
GKFF
GS
RHJA
Palogic Value Management's ASPN Position: Q1 2026 in Review
Palogic Value Management reduced its Aspen Aerogels (ASPN) stake by 14% in Q1 2026, selling an estimated $253K and leaving 450,000 shares worth $1.54M. The position accounts for 0.65% of the portfolio, ranked #41.
Palogic Value Management first reported a position in ASPN in Q4 2022 and has held it in 12 quarters since. The position peaked at $3.61M in Q2 2025. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.
- Palogic Value Management held 450,000 shares of Aspen Aerogels worth $1.54M as of Q1 2026.
- Palogic Value Management sold 75,000 Aspen Aerogels shares in Q1 2026, an estimated $253K.
- Aspen Aerogels made up 0.65% of Palogic Value Management's portfolio in Q1 2026, its #41 holding.
- Palogic Value Management first reported a position in Aspen Aerogels in Q4 2022 and has held it in 12 quarters since.
- Palogic Value Management's Aspen Aerogels position peaked at $3.61M in Q2 2025.
- 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.
Based on Palogic Value Management's 13F filing for Q1 2026, filed 15 May 2026.